Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
454 Leser
Artikel bewerten:
(2)

Emergent Health Corp.: Emergent Health's Chief Marketing Officer Marvin Segel, Son of QVC Founder Joseph Segel to Appear Today on the Digital Stock & Investment News Network Rich TV Live at 1:00 PM ET

KING OF PRUSSIA, PA / ACCESSWIRE / February 22, 2022 / Emergent Health Corp. (OTC PINK:EMGE) announced today that its' Chief Marketing Officer Marvin Segel, son of QVC founder Joseph Segel to appear today on the Digital Stock & Investment News Network Rich TV Live, a financial focused digital network. The interview will air this afternoon at 1 PM ET on Rich TV Live and will be available on Emergent's social media platforms shortly thereafter.

A person wearing glasses

Description automatically generated with medium confidence

Segel will discuss his background, past track record, business and entrepreneurial success, status of Emergent, his role, key goals and milestones for the next 12 months as well as other potential opportunities available to Emergent.

ABOUT RICH TV LIVE
Rich TV has been sharing company news and updates on YouTube, Facebook, LinkedIn, Twitter, Instagram, Blogger and many other social media sites since 2017 with a community of 80,000 members. Rich TV's daily show on YouTube helps investors access in-depth information about companies through CEO interviews, company overviews and Video press releases. Rich TV's videos, shared on 25 different social media platforms, bring more visibility to companies that are under exposed. The network's mission is to bring viewers the best trading information and ideas through their trading club. All information presented on Rich TV Live is for educational and entertainment purposes. They are not licensed advisors.

ABOUT EMERGENT HEALTH CORPORATION
Emergent Health Corp. develops and sells emerging health technologies, nutraceuticals, and phytonutritionals along with content to educate the consumer on a healthier lifestyle. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach (combined with a proper diet and exercise program); EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, online and various other retail outlets throughout the United States and internationally. PharmaZu Corp., its newly acquired subsidiary is a pure play, e-commerce products and service provider focused on the pet pharmacy, vet telehealth and pet wellness businesses. Emergent Health does not claim any of its products are approved by the FDA to diagnose, treat or prevent/cure any disease. Always consult with your doctor before taking any new product.

SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

FOR MORE INFORMATION, PLEASE CONTACT:
James Zimbler, CEO
info@emergenthealthcorp.com
631-806-1420

SOURCE: Emergent Health Corp.



View source version on accesswire.com:
https://www.accesswire.com/689728/Emergent-Healths-Chief-Marketing-Officer-Marvin-Segel-Son-of-QVC-Founder-Joseph-Segel-to-Appear-Today-on-the-Digital-Stock-Investment-News-Network-Rich-TV-Live-at-100-PM-ET

© 2022 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.